Cancer Immunotherapy Stocks List

Symbol Grade Name
NLNK NewLink Genetics Corporation
IMUC ImmunoCellular Therapeutics, Ltd.
IMDZ Immune Design Corp.
TRIL Trillium Therapeutics Inc.
IOVA Iovance Biotherapeutics, Inc.
ADRO Aduro Biotech, Inc.
ADAP Adaptimmune Therapeutics plc
CLBS Caladrius Biosciences, Inc.
PDSB PDS Biotechnology Corporation
CRVS Corvus Pharmaceuticals, Inc.
MRUS Merus N.V.
MRKR Marker Therapeutics, Inc.
ZYME Zymeworks Inc.
CKPT Checkpoint Therapeutics, Inc.
MBIO Mustang Bio, Inc.
SURF Surface Oncology, Inc.
IMV IMV Inc.
NTGN Neon Therapeutics, Inc.
FTSV Forty Seven, Inc.
GRTS Gritstone Oncology, Inc.
HARP Harpoon Therapeutics, Inc.

Recent Signals

Date Stock Signal Type
2019-03-22 ADAP New 52 Week Closing Low Bearish
2019-03-22 ADRO Bollinger Band Squeeze Range Contraction
2019-03-22 ADRO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-03-22 ADRO Stochastic Reached Oversold Weakness
2019-03-22 CKPT Wide Range Bar Range Expansion
2019-03-22 CKPT 200 DMA Resistance Bearish
2019-03-22 CKPT 20 DMA Resistance Bearish
2019-03-22 CKPT 50 DMA Resistance Bearish
2019-03-22 CKPT Expansion Pivot Sell Setup Bearish Swing Setup
2019-03-22 CKPT Bollinger Band Squeeze Range Contraction
2019-03-22 CKPT Lizard Bearish Bearish Day Trade Setup
2019-03-22 CKPT Doji - Bearish? Reversal
2019-03-22 CKPT Doji - Bullish? Reversal
2019-03-22 CKPT Shooting Star Candlestick Bearish
2019-03-22 CLBS Lower Bollinger Band Walk Weakness
2019-03-22 CRVS Expansion Pivot Sell Setup Bearish Swing Setup
2019-03-22 CRVS MACD Bearish Centerline Cross Bearish
2019-03-22 CRVS Fell Below 50 DMA Bearish
2019-03-22 FTSV Fell Below 20 DMA Bearish
2019-03-22 FTSV Bollinger Band Squeeze Range Contraction
2019-03-22 FTSV MACD Bearish Signal Line Cross Bearish
2019-03-22 GRTS NR7 Range Contraction
2019-03-22 GRTS Calm After Storm Range Contraction
2019-03-22 HARP Hot IPO Pullback Bullish Swing Setup
2019-03-22 HARP New 52 Week Closing Low Bearish
2019-03-22 IMV New 52 Week Closing Low Bearish
2019-03-22 IMV Expansion Breakdown Bearish Swing Setup
2019-03-22 IMV MACD Bearish Signal Line Cross Bearish
2019-03-22 IMV New 52 Week Low Weakness
2019-03-22 IOVA Fell Below 50 DMA Bearish
2019-03-22 IOVA Expansion Pivot Sell Setup Bearish Swing Setup
2019-03-22 IOVA 180 Bearish Setup Bearish Swing Setup
2019-03-22 IOVA Stochastic Reached Oversold Weakness
2019-03-22 MBIO MACD Bearish Centerline Cross Bearish
2019-03-22 MBIO New Downtrend Bearish
2019-03-22 MBIO Fell Below 50 DMA Bearish
2019-03-22 MRKR 20 DMA Support Bullish
2019-03-22 MRKR 50 DMA Support Bullish
2019-03-22 MRUS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-03-22 MRUS Hammer Candlestick Bullish
2019-03-22 MRUS Doji - Bullish? Reversal
2019-03-22 MRUS Lizard Bullish Bullish Day Trade Setup
2019-03-22 MRUS 20 DMA Support Bullish
2019-03-22 MRUS 50 DMA Support Bullish
2019-03-22 NLNK Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-03-22 NLNK 1,2,3 Pullback Bullish Bullish Swing Setup
2019-03-22 NLNK Upper Bollinger Band Walk Strength
2019-03-22 NTGN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-03-22 NTGN Stochastic Reached Oversold Weakness
2019-03-22 PDSB Narrow Range Bar Range Contraction
2019-03-22 PDSB Stochastic Reached Oversold Weakness
2019-03-22 PDSB MACD Bearish Centerline Cross Bearish
2019-03-22 PDSB Calm After Storm Range Contraction
2019-03-22 SURF 20 DMA Resistance Bearish
2019-03-22 TRIL 20 DMA Resistance Bearish
2019-03-22 TRIL Bollinger Band Squeeze Range Contraction
2019-03-22 ZYME MACD Bearish Centerline Cross Bearish

Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.

More about Cancer Immunotherapy